If you live with depersonalization or derealization, the idea of a treatment that causes dissociation probably sounds alarming, maybe even absurd. You already know what it feels like to watch your own life from behind glass, to look at your hands and wonder whether they are really yours, to move through a world that seems flat and unreal. Why would anyone with that experience willingly take a drug famous for producing something similar?

It is a fair question, and it deserves a straight answer rather than a sales pitch. This is one of the topics where we think honesty serves people better than enthusiasm. So let us walk through what depersonalization and derealization actually are, what ketamine does and does not do to that state, and how we think about safety when someone with this history asks about treatment.

What Depersonalization and Derealization Are

Depersonalization is the sense of being detached from yourself, from your thoughts, feelings, body, or actions, as if you are an observer of your own life rather than a participant. Derealization is the same detachment aimed outward: the world feels unreal, dreamlike, foggy, or somehow staged. Most people feel a flicker of this at some point, often under exhaustion or acute stress, and it means nothing.

Depersonalization-derealization disorder, DPDR, is the version that sticks. The detachment becomes persistent or recurrent, lasts for weeks to years, and causes genuine distress or interferes with daily life, while the person remains fully aware that what they are experiencing is not literally true. That preserved awareness is part of the diagnosis and part of what makes it so uncomfortable: you know the fog is not reality, and you still cannot get out of it.

DPDR rarely arrives alone. It commonly rides alongside anxiety, depression, panic, and trauma, and it can be a prominent feature of PTSD. This overlap matters a great deal for the ketamine question, and we will come back to it.

The Glutamate Connection

Here is where the science gets genuinely interesting. Some research has proposed that depersonalization involves an imbalance in glutamate signaling, the same neurotransmitter system ketamine acts on. Ketamine blocks the NMDA glutamate receptor, and NMDA-receptor activity is one of the pathways researchers have implicated in dissociative states. In other words, the very system that ketamine touches is one of the systems thought to be involved in depersonalization itself.

This cuts both ways, which is exactly the point. On one hand, it is part of why ketamine can produce dissociation. On the other, it is why some researchers have wondered whether carefully targeting that system could, in principle, help recalibrate it. Right now that second idea is a hypothesis, not a treatment. We mention the mechanism not to build a case for ketamine, but because understanding it explains both the risk and the theoretical curiosity in one breath.

Ketamine Dissociation Is Not the Same as DPDR

This distinction is the most important thing in the article, so we want to be precise about it.

The dissociation ketamine produces is a temporary, dose-dependent, monitored effect. It comes on during the infusion, peaks while the medication is active, and resolves as it clears, usually within an hour or two, in a monitored clinical setting. Roughly 40 percent of people receiving ketamine notice some dissociative or perceptual change during a session. In a controlled setting, with the right dose and preparation, it is a passing experience rather than a lasting one.

DPDR is the opposite in almost every dimension: uninvited, unbounded in time, unsupervised, and distressing precisely because it will not end. Confusing the two, treating a brief supervised drug effect as though it were the same thing as a chronic disorder, leads people to the wrong conclusions in both directions. Some panic unnecessarily; others assume ketamine must be a natural fit for treating detachment. Neither follows.

The Real Risk: Triggering or Worsening DPDR

We are not going to soft-pedal this. Recreational and unsupervised use of dissociative and psychedelic drugs, including ketamine, cannabis, and hallucinogens, is a recognized trigger for depersonalization episodes, and in some cases can precipitate a more persistent DPDR-like state in vulnerable people. That is a documented risk, and it is the single biggest reason we treat a history of depersonalization as a red flag that demands a careful conversation before anything else.

A clinical infusion is a very different context from a recreational dose, controlled amount, medical monitoring, a calm environment, preparation, and integration afterward. Those safeguards meaningfully change the risk profile. But they do not erase it. For someone whose primary problem is depersonalization, the possibility that a dissociative medication could deepen the very thing they are trying to escape is a serious consideration, and it is why ketamine is not a routine answer here.

The dissociation ketamine produces is transient and resolves as the drug clears. Depersonalization-derealization disorder is a chronic condition. The clinical task is to tell the two apart, and to make sure a temporary effect never becomes a lasting one. — Our approach at Music City Ketamine

Does the Dissociation Even Do the Healing?

People sometimes assume ketamine works because of the dissociative experience, that the trip is the treatment. The evidence points the other way. A 2024 review in the International Journal of Neuropsychopharmacology examined this question and found that the acute dissociative effect during an infusion is largely disconnected from later improvement in depression or suicidal thinking. Some data even suggest that less dissociation is associated with slightly better mood outcomes.

We find this genuinely reassuring in the context of depersonalization. It means the therapeutic benefit does not require an intense, disorienting experience. The aim of a well-run session is calm and containment, not spectacle. For someone who is understandably wary of feeling detached, this reframes what treatment is supposed to look like: quiet, controlled, and as grounded as a ketamine session can be. Our overview of how ketamine works explains why the lasting effects come from what happens in the days after the infusion, not from the experience itself.

When Ketamine Might Still Make Sense

Given all these cautions, is there any scenario where ketamine is reasonable for someone who experiences depersonalization? Sometimes, yes, and the distinction hinges on why the detachment is there.

When depersonalization is a symptom of an underlying condition, severe depression, an anxiety or panic disorder, or PTSD, rather than a freestanding DPDR diagnosis, treating that root condition can sometimes ease the detachment along with the other symptoms. Many people with treatment-resistant depression describe a numb, unreal, cut-off quality to their days, and as the depression lifts, that quality can lift too. In cases like these, the depersonalization is downstream of something ketamine has real evidence for.

When depersonalization is the primary problem, standalone DPDR, the calculus is different. There is no established, evidence-based role for ketamine in primary DPDR, and the first-line treatments remain psychotherapy, especially cognitive behavioral therapy, and sometimes SSRIs or SNRIs. In that situation we would be cautious and would not lead with ketamine.

Sorting out which category someone falls into is not something to guess at. It is the whole job of a careful evaluation, and it is exactly the kind of question we work through before recommending anything. You can read more about how we think about who is and isn’t a good candidate in our piece on whether ketamine therapy is safe.

How We Handle This at Our Clinic

If you come to us with any history of feeling detached from yourself or the world, we want to hear about it in detail, and it will shape everything that follows. In practice that means:

The Bottom Line

Ketamine and depersonalization have a real and complicated relationship. The drug can cause temporary dissociation, can in rare cases worsen a persistent detached state, and is not an established treatment for DPDR itself. At the same time, when detachment is a symptom of depression, anxiety, or PTSD, treating that underlying condition may ease it, and the therapeutic benefit does not require an intense dissociative experience to appear.

If you have wondered about any of this for yourself, the most useful next step is not a decision, it is a conversation with someone who will take the risk seriously and give you a candid read. We are a small team in Franklin, and we would rather help you think this through carefully than talk you into anything.